Gomez and López-Hernández syndrome
Gomez and López-Hernández syndrome is a rare genetic disorder characterized by a variety of physical and neurological abnormalities. It was first described by the medical researchers Dr. Gomez and Dr. López-Hernández in the late 20th century.
Symptoms and Signs[edit | edit source]
The syndrome is characterized by a wide range of symptoms, including intellectual disability, seizures, microcephaly (small head size), hypotonia (low muscle tone), and distinctive facial features. Other symptoms may include growth retardation, hearing loss, and vision problems. The severity of these symptoms can vary greatly among affected individuals.
Causes[edit | edit source]
Gomez and López-Hernández syndrome is caused by mutations in the TBC1D24 gene. This gene provides instructions for making a protein that is involved in the regulation of cell division and cell growth. Mutations in the TBC1D24 gene disrupt the normal function of this protein, leading to the various symptoms associated with the syndrome.
Diagnosis[edit | edit source]
Diagnosis of Gomez and López-Hernández syndrome is based on the presence of characteristic clinical features and confirmed by genetic testing to identify mutations in the TBC1D24 gene.
Treatment[edit | edit source]
There is currently no cure for Gomez and López-Hernández syndrome. Treatment is symptomatic and supportive, and may include physical therapy, occupational therapy, and speech therapy to help manage the symptoms and improve the quality of life for affected individuals.
Prognosis[edit | edit source]
The prognosis for individuals with Gomez and López-Hernández syndrome varies depending on the severity of symptoms. Some individuals may have a normal lifespan with appropriate management of symptoms, while others may have a shortened lifespan due to complications of the disorder.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Gomez and López-Hernández syndrome is a rare disease.
| Gomez and López-Hernández syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
